Improving adherence to Ticagrelor in patients after acute coronary syndrome: Results from the PROGRESS trial.

CONCLUSION: The PROGRESS trial showed a net reduction in DAPT disruption in patients followed-up with clinical (in-person) follow-up visits in a dedicated outpatient clinic compared with those scheduled for phone interviews only.
PMID: 31124422 [PubMed - as supplied by publisher]

Source: Current Vascular Pharmacology - May 23, 2019 Category: Drugs & Pharmacology Authors: Crisci M, Gragnano F, Di Maio M, Diana V, Moscarella E, Pariggiano I, Di Maio D, Concilio C, Taglialatela V, Fimiani F, Cesaro A, Cirillo PL, Calabrò P Tags: Curr Vasc Pharmacol Source Type: research